In vivo experiments conducted by Su et al. showed that overexpression of COP1 increases tumor growth in HCT-116 colon cancer xenografts, indicating COP1 has a tumorigenic role in colon cancer through suppression of the p53 tumor suppressor pathway. The gene discussed is COP1; the disease is colonic neoplasm.